1. Abood R. Pharmacy Practice and the Law. 5th ed. Sudbury (MA): Jones and Bartlett Publishers; 2007.
2. Aronsson T, Bergman M, Rudholm N. The impact of generic drug competition on brand name market shares. Evidence from micro data. Review of Industrial Organization. 2001;19:425–35.
3. Arruñada B. Managing Competition in Professional Services and the Burden of Inertia. In: Ehlermann C-D, Atanasiu I, editors. European Competition Law Annual 2004: The Relationship between Competition Law and the (Liberal) Professions. Oxford and Portland, Oregon: Hart Publishing; 2006. p. 51–71.
4. Bae JP. Drug patent expirations and the speed of generic entry. Health Services Research. 1997;32:187–201.
5. Bergman M, Rudholm N. The relative importance of actual and potential competition: Empirical evidence from the pharmaceuticals market. J Industrial Economics. 2003;51:455–67.